Contralateral second dose improves antibody responses to a two-dose mRNA vaccination regimen
Description
CONCLUSIONS: In previously unexposed adults receiving an initial vaccine series with the BNT162b2 mRNA COVID-19 vaccine, contralateral boosting substantially increases antibody magnitude and breadth at times beyond 3 weeks after vaccination. This
